Preoperative chemotherapy for stage IIIB extremity soft tissue sarcoma: Long-term results from a single institution

Journal of Clinical Oncology

Volumn 15, Issue 12, 1997, Pages 3481-3487

  Pisters, Peter W ^a   Patel, Shreyaskumar R ^a   Varma, Datla G K ^a   Cheng, Su Chun ^a   Chen, Nancy P ^a   Nguyen, H T B ^a   Feig, Barry W ^a   Pollack, Alan ^a   Pollock, Raphael E ^a   Benjamin, Robert S ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOPHOSPHAMIDE; DACARBAZINE; DOXORUBICIN; IFOSFAMIDE;

ADULT; AGED; CANCER CHEMOTHERAPY; CANCER STAGING; CANCER SURVIVAL; CLINICAL PROTOCOL; FASCIA; FEMALE; HIGH RISK POPULATION; HUMAN; LEG; LIMB SALVAGE; MAJOR CLINICAL STUDY; MALE; MALIGNANT FIBROUS HISTIOCYTOMA; METASTASIS; PRIORITY JOURNAL; REVIEW; SOFT TISSUE SARCOMA; TREATMENT OUTCOME; TUMOR RECURRENCE; TUMOR VOLUME;

EID: 0030699251     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.1997.15.12.3481     Document Type: Review

References (15)

1. Pisters PWT, Leung DHY, Woodruff J, et al: Analysis of prognostic factors in 1041 patients with localized soft tissue sarcomas of the extremities. J Clin Oncol 14:1679-1689, 1996
2. Gaynor JJ, Tan CC, Casper ES, et al: Refinement of clinico-pathologic staging for localized soft tissue sarcoma of the extremity: A study of 423 adults. J Clin Oncol 10:1317-1329, 1992
3. Pezzi CM, Pollock RE, Evans HL, et al: Preoperative chemotherapy for soft-tissue sarcomas of the extremities. Ann Surg 211:476-481, 1990
4. Beahrs OH, Henson DE, Hutter RVP, et al (eds): Soft tissues, in American Joint Committee on Cancer Manual for Staging of Cancer. Philadelphia, PA. Lippincott, 1992, pp 131-133
5. Hajdu SI, Shiu MH, Brennan MF: The role of the pathologist in the management of soft tissue sarcomas. World J Surg 12:326-331, 1988
6. Trojani M, Contesso G, Coindre JM, et al: Soft-tissue sarcomas of adults: Study of pathological prognostic variables and definition of a histopathological grading system. Int J Cancer 33:37-42, 1984
7. Kaplan E, Meier P: Nonparametric estimation from incomplete observations. J Am Stat Assoc 53:457-481, 1958
8. Greenwood M: The Natural Duration of Cancer. Reports on Public Health and Medical Subjects, vol 33. London, United Kingdom, Her Majesty's Stationary Office, 1926, pp 1-26
9. Anderson JR, Cain KC, Gelber RD: Analysis of survival by tumor response. J Clin Oncol 1:710-719, 1983
10. Bramwell V, Rouesse J, Steward W, et al: Adjuvant CY-VADIC chemotherapy for adult soft tissue sarcoma - Reduced local recurrence but no improvement in survival: A study of the European Organization for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group. J Clin Oncol 12:1137-1149, 1994
11. Casper ES, Gaynor JJ, Harrison LB, et al: Preoperative and postoperative adjuvant combination chemotherapy for adults with high grade soft tissue sarcoma. Cancer 73:1644-1651, 1994
12. O'Bryan RM, Baker LH, Gottlieb JE, et al: Dose response evaluation of Adriamycin in human neoplasia. Cancer 39:1940-1948, 1977
13. Pisters PWT, Patel SR, Varma DGK, et al: Pathologic complete response (pCR) following preoperative multimodality therapy for stage IIIB extremity soft tissue sarcoma (STS): Implications for the design of multimodality trials. Proc Am Soc Clin Oncol 16:1795, 1997 (abstr)
14. Gortzak E, Rouesse J, Verwey J, et al: Randomised phase II study of neoadjuvant chemotherapy in soft tissue sarcomas in adults. Protocol 62874. Eur J Cancer 29A:S183, 1993 (suppl 6, abstr)
15. Tierney JF: A meta-analysis using individual patient data from randomised clinical trials (RCTS) of adjuvant chemotherapy for soft tissue sarcomas (STS). Proc Am Soc Clin Oncol 15:2024, 1996 (abstr)